BOM:524348 (India)
Â
Shs Dematerialised
₹
490.75
(-2.7%)
Apr 15
Business Description
Aarti Drugs Ltd
ISIN : INE767A01016
Share Class Description:
BOM:524348: Shs DematerialisedCompare
Compare
Traded in other countries / regions
AARTIDRUGS.India IPO Date
1993-09-13Description
Aarti Drugs Ltd is a pharmaceutical company. It offers active pharmaceutical ingredients (APIs) in a range of therapeutic categories, such as anti-inflammatory, cardioprotectant, antibiotic, antidiabetic, and vitamins among others. The product offerings of the company comprise Aceclofenac, Celecoxib, Moxifloxacin, and others. The firm generates the majority of its revenue from India.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.04 | |||||
| Equity-to-Asset | 0.51 | |||||
| Debt-to-Equity | 0.49 | |||||
| Debt-to-EBITDA | 1.8 | |||||
| Interest Coverage | 8.67 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 4.21 | |||||
| Beneish M-Score | -2.27 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 14.8 | |||||
| 3-Year EBITDA Growth Rate | 5 | |||||
| 3-Year EPS without NRI Growth Rate | 6.1 | |||||
| 3-Year Book Growth Rate | 22.5 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 68.61 | |||||
| 9-Day RSI | 64.91 | |||||
| 14-Day RSI | 59.43 | |||||
| 6-1 Month Momentum % | -11.8 | |||||
| 12-1 Month Momentum % | 10.34 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.61 | |||||
| Quick Ratio | 0.99 | |||||
| Cash Ratio | 0.03 | |||||
| Days Inventory | 92.1 | |||||
| Days Sales Outstanding | 104.54 | |||||
| Days Payable | 75.6 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.2 | |||||
| Dividend Payout Ratio | 0.05 | |||||
| 3-Year Dividend Growth Rate | 10.1 | |||||
| Forward Dividend Yield % | 0.2 | |||||
| 5-Year Yield-on-Cost % | 1.16 | |||||
| 3-Year Average Share Buyback Ratio | 0.2 | |||||
| Shareholder Yield % | -0.55 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 19.64 | |||||
| Operating Margin % | 10.8 | |||||
| Net Margin % | 6.8 | |||||
| FCF Margin % | -1.15 | |||||
| ROE % | 15.39 | |||||
| ROA % | 7.68 | |||||
| ROIC % | 11.29 | |||||
| ROC (Joel Greenblatt) % | 15.55 | |||||
| ROCE % | 19.18 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 25.86 | |||||
| PE Ratio without NRI | 25.69 | |||||
| Shiller PE Ratio | 28.63 | |||||
| Price-to-Owner-Earnings | 150.1 | |||||
| PEG Ratio | 2.01 | |||||
| PS Ratio | 1.76 | |||||
| PB Ratio | 3.83 | |||||
| Price-to-Tangible-Book | 3.73 | |||||
| Price-to-Operating-Cash-Flow | 34.8 | |||||
| EV-to-EBIT | 18.28 | |||||
| EV-to-EBITDA | 15.47 | |||||
| EV-to-Revenue | 1.91 | |||||
| EV-to-FCF | -169.87 | |||||
| Price-to-Projected-FCF | 2.91 | |||||
| Price-to-DCF (Earnings Based) | 1.29 | |||||
| Price-to-Median-PS-Value | 1.4 | |||||
| Price-to-Peter-Lynch-Fair-Value | 3.09 | |||||
| Price-to-Graham-Number | 2.04 | |||||
| Price-to-Net-Current-Asset-Value | 23.05 | |||||
| Earnings Yield (Greenblatt) % | 5.47 | |||||
| FCF Yield % | -0.68 | |||||
| Forward Rate of Return (Yacktman) % | 13.59 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Aarti Drugs Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 26,510.036 | ||
| EPS (TTM) (₹) | 19.503 | ||
| Beta | 0.71 | ||
| Volatility % | 44.77 | ||
| 14-Day RSI | 59.43 | ||
| 14-Day ATR (₹) | 17.070801 | ||
| 20-Day SMA (₹) | 466.0925 | ||
| 12-1 Month Momentum % | 10.34 | ||
| 52-Week Range (₹) | 405.45 - 645 | ||
| Shares Outstanding (Mil) | 91.94 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Aarti Drugs Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Aarti Drugs Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Aarti Drugs Ltd Frequently Asked Questions
What is Aarti Drugs Ltd(BOM:524348)'s stock price today?
The current price of BOM:524348 is ₹490.75. The 52 week high of BOM:524348 is ₹645.00 and 52 week low is ₹405.45.
When is next earnings date of Aarti Drugs Ltd(BOM:524348)?
The next earnings date of Aarti Drugs Ltd(BOM:524348) is 2024-04-29 Est..
Does Aarti Drugs Ltd(BOM:524348) pay dividends? If so, how much?
The Dividend Yield %  of Aarti Drugs Ltd(BOM:524348) is 0.2% (As of Today), Highest Dividend Payout Ratio of Aarti Drugs Ltd(BOM:524348) was 0.24. The lowest was 0.03. And the median was 0.07. The  Forward Dividend Yield % of Aarti Drugs Ltd(BOM:524348) is 0.2%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers